~~<i id='4339C38674'><strike id='4339C38674'><tt id='4339C38674'><pre id='4339C38674'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

explore

author：entertainment 2025-10-01 03:50:32 - browse：131

Pharmacists increasingly are being asked to make drugs in bulk for hospitals that are in short supply, and they’re even beginning to make chemotherapies. But some in the industry worry about the unintended consequences of overreliance.

Hospitals’ reliance on pharmacist-made drugs, a practice called compounding, has risen in step with worsening drug shortages.

When the American Society of Health-System Pharmacists surveyed its members this past summer, 59% said they increased purchases from compounders because of drug shortages.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： A solution to the after

explore

hotspot

Wikipedia

focus

hotspot

WilfredoLee/APMedicareAdvantagememberscontinuetogotothedoctorandgethealthcareproceduresalotmorethanp

WSS

White House finalizes ITC's import ban of latest Apple Watches

Obesity drugs seen as possible treatment for liver disease MASH

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

3 medical device trends to watch in 2024

A single drug, study failures leave Anavex with nothing but cash

New weight loss drugs work. But how can they best be used?

focus

explore

explore

Anesthesiologist group: stop taking Ozempic before surgery

3 medical device trends to watch in 2024

ChatGPT in medicine: STAT answers readers' burning questions

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

Alkermes shareholders re

Ed Silverman on new gene therapies, biosimilars, coffee, and more

23andMe had bad news about my health. I wish a person had delivered it

GSK Flovent asthma inhalers replaced by authorized generics

Psychedelics group wrestles with new pharma identity

New documents shed light on MD Anderson Cancer Institute feud

hotspot

Alabama frozen embryo ruling has major implications for IVF clinics

A new nitrogen execution bill also undermines medical licensing

U.K. sequencing study surfaces new findings about tumor DNA

NIH study of ME/CFS points to clear biological hallmarks

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

AdventHealth escalates lawsuit against insurance vendor Multiplan

Wikipedia

focus

focus

hotspot